Director dealings: TUI, Oxford Biomedica board members linked to buys
Sharecast
Published Sep 27, 2023 13:46
Updated Sep 27, 2023 14:15
Director dealings: TUI, Oxford Biomedica board members linked to buys
Sharecast - The travel giant said Sebastian Ebel picked up 49,900 shares on 26 September in a single transaction outside a trading venue.
Ebel paid €4.99 for each share, valuing the transaction at a total of €224,325.21 (£194,816.35).
Elsewhere, Oxford BioMedica PLC (LON:OXB) disclosed a purchase linked to one of its non-executive directors.
The company said Sandra Juliet Ferera Hayden bought 12,000 shares on 26 September in a single transaction on the London Stock Exchange.
Hayden paid 293.5p for each share, valuing the purchase at £35,220.00.
In its disclosure, Oxford Biomedica said Sandra Hayden is a person closely associated with non-executive director Michael Hayden.
At 1304 BST, shares in TUI (LON:TUIT) were up 3.39% in London at 451.6p, while those in Oxford Biomedica were 1.72% weaker at 286.5p.
Reporting by Josh White for Sharecast.com.
Read more on Sharecast.com
Get The App
Written By: Sharecast
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.